We've got news for you.

Register on BusinessLIVE at no cost to receive newsletters, read exclusive articles & more.
Register now

Intellectual property (IP) rights are at the heart of global supplies and access to Covid-19 vaccines. US President Joe Biden’s administration has expressed its support for a patent waiver to boost vaccine production in a climate of throttled supply and dominance of vaccine manufacturing by a few Western companies.

America’s support could be a significant boost in the fight to increase global supplies of vaccines and loosen the grip of Western pharmaceutical companies that have used the pandemic, perversely, to bulk up profits while throttling governments of poor nations that are going through fiscal strain. However, there is still a long struggle ahead to get the patent waiver through the World Trade Organization (WTO)...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now

Would you like to comment on this article?
Register (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.

Commenting is subject to our house rules.